Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | C162* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | VHL C162* results in a premature truncation of the Vhl protein at amino acid 162 of 213 (UniProt.org). C162* has not been characterized, however, due to the effects of other truncation mutations downstream of C162 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL inact mut VHL C162* |
Transcript | NM_000551.4 |
gDNA | chr3:g.10149809C>A |
cDNA | c.486C>A |
Protein | p.C162* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551.3 | chr3:g.10149809C>A | c.486C>A | p.C162* | RefSeq | GRCh38/hg38 |
NM_000551.4 | chr3:g.10149809C>A | c.486C>A | p.C162* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|